Search Orphan Drug Designations and Approvals
-
Generic Name: | 18-(p-[131I]-iodophenyl)octadecyl phosphocholine |
---|---|
Date Designated: | 09/24/2018 |
Orphan Designation: | Treatment of osteosarcoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Cellectar Biosciences, Inc. 3301 Agriculture Drive Madison, Wisconsin 53716 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-